LifeStance Health (LFST) Depreciation & Amortization (CF) (2020 - 2026)

LifeStance Health (LFST) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $13.3 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 3.18% year-over-year to $13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.3 million (down 12.6% YoY) and the FY2025 annual result came in at $54.8 million, down 22.83% from the prior year.
• Depreciation & Amortization (CF) declined to $13.3 million in Q1 2026 per LFST's latest filing, from $13.4 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $22.6 million in Q1 2024 and bottomed at $13.3 million in Q1 2026.
• The 5-year median for Depreciation & Amortization (CF) is $16.7 million (2022), against an average of $17.0 million.
• The widest annual swing landed in 2022, when Depreciation & Amortization (CF) jumped 31.07%; it then slumped 39.04% in 2025.
• Tracing LFST's Depreciation & Amortization (CF) over 5 years: stood at $18.9 million in 2022, then grew by 17.63% to $22.2 million in 2023, then tumbled by 33.96% to $14.7 million in 2024, then decreased by 8.43% to $13.4 million in 2025, then declined by 0.86% to $13.3 million in 2026.
• Per Business Quant, the three latest LFST Depreciation & Amortization (CF) figures stand at $13.3 million (Q1 2026), $13.4 million (Q4 2025), and $13.6 million (Q3 2025).

Peer Comparison